HomeComparePCLB vs MRK

PCLB vs MRK: Dividend Comparison 2026

PCLB yields 2.88% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PCLB wins by $44.5K in total portfolio value· pulled ahead in Year 5
10 years
PCLB
PCLB
● Live price
2.88%
Share price
$37.50
Annual div
$1.08
5Y div CAGR
42.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.2K
Annual income
$33,690.88
Full PCLB calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — PCLB vs MRK

📍 PCLB pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPCLBMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PCLB + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PCLB pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCLB
Annual income on $10K today (after 15% tax)
$244.80/yr
After 10yr DRIP, annual income (after tax)
$28,637.25/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, PCLB beats the other by $20,040.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCLB + MRK for your $10,000?

PCLB: 50%MRK: 50%
100% MRK50/50100% PCLB
Portfolio after 10yr
$80.0K
Annual income
$21,902.33/yr
Blended yield
27.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PCLB
No analyst data
Altman Z
0.1
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCLB buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPCLBMRK
Forward yield2.88%2.81%
Annual dividend / share$1.08$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR42.1%32.7%
Portfolio after 10y$102.2K$57.7K
Annual income after 10y$33,690.88$10,113.78
Total dividends collected$74.8K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PCLB vs MRK ($10,000, DRIP)

YearPCLB PortfolioPCLB Income/yrMRK PortfolioMRK Income/yrGap
1$11,109$409.25$11,213$373.04$104.00MRK
2$12,491$603.78$12,667$512.06$176.00MRK
3$14,267$901.56$14,439$708.14$172.00MRK
4$16,633$1,367.53$16,640$988.16$7.00MRK
5← crossover$19,914$2,117.35$19,432$1,394.07+$482.00PCLB
6$24,675$3,366.71$23,057$1,992.90+$1.6KPCLB
7$31,942$5,539.98$27,889$2,894.79+$4.1KPCLB
8$43,702$9,524.14$34,518$4,286.29+$9.2KPCLB
9$64,067$17,305.14$43,912$6,494.35+$20.2KPCLB
10$102,242$33,690.88$57,714$10,113.78+$44.5KPCLB

PCLB vs MRK: Complete Analysis 2026

PCLBStock

Pinnacle Bancshares, Inc. operates as the bank holding company for Pinnacle Bank that provides various banking products and services. The company provides checking accounts, savings accounts, and demand and time deposits. It also offers personal lending for automobile, boat, jet ski, motor home, travel trailers, manufactured home, tractor, ATV, personal line of credit, and others; mortgage products, such as residential purchase and refinance, investment property, consumer construction, consumer 2nd mortgage, veterans administration loans, federal housing administration loans, land loans, home equity line of credit, and home improvement/renovation; commercial lending products, including purchase, construction, and refinance of residential rental property and commercial real estate, as well as residential rental property improvements, land acquisition, investment, and development; commercial construction; and SBA lending. In addition, the company provides digital banking, card, cash management, and merchant services. It operates seven offices in the central and northwest Alabama. Pinnacle Bancshares, Inc. was incorporated in 1996 and is based in Jasper, Alabama.

Full PCLB Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PCLB vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCLB vs SCHDPCLB vs JEPIPCLB vs OPCLB vs KOPCLB vs MAINPCLB vs JNJPCLB vs ABBVPCLB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.